Gross Margin
13.05%vs Specialty Chemicals peers Updated Aug 21, 2026Profit Margin
-1.16%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
1.39%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
-0.34%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
-0.75%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
1.31BCNY195.45M · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
2.89CNYUpdated Aug 21, 2026Quarterly Revenue Growth
6.00%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
153.49MCNY22.83M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
171.01MCNY25.43M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
-15.26MCNY-2.27M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
-30.10%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
157.11MCNY23.36M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
120.50MCNY17.92M · vs all stocks (USD) Updated Aug 21, 2026Trailing Annual Dividend Rate
0.2150CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.36%Updated Aug 21, 2026Payout Ratio
148.68%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -537.5%.Updated Aug 21, 2026Revenue
1.30BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.12BCNYFY2025 · Dec 31, 2025Gross Profit
176.49MCNYFY2025 · Dec 31, 2025Operating Income
14.95MCNY2.22M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-22.82MCNYFY2025 · Dec 31, 2025Income Tax Expense
-9.90MCNYFY2025 · Dec 31, 2025Net Income
-12.92MCNYFY2025 · Dec 31, 2025EBIT
2.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
171.01MCNYFY2025 · Dec 31, 2025Research & Development
32.09MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
38.04MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.49MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
25.37MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0311CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0311CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
415.45MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
415.45MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-12.92MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-121.59MCNYFY2025 · Dec 31, 2025Free Cash Flow
-196.38MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
160.69MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-12.92MCNYFY2025 · Dec 31, 2025Other Non-cash Items
37.04MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-75.20MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-70.50MCNYFY2025 · Dec 31, 2025Capital Expenditures
-74.80MCNYFY2025 · Dec 31, 2025Purchase of Investments
-673.00MCNYFY2025 · Dec 31, 2025Sale of Investments
679.32MCNYFY2025 · Dec 31, 2025Other Investing Activity
8.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-60.48MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.04BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.08BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-68.01MCNYFY2025 · Dec 31, 2025Other Financing Charges
321.51KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-106.03MCNYFY2025 · Dec 31, 2025